Metis Global Partners LLC Increases Stake in ICL Group Ltd (NYSE:ICL)

Metis Global Partners LLC raised its holdings in ICL Group Ltd (NYSE:ICL) by 25.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 156,749 shares of the basic materials company’s stock after buying an additional 31,461 shares during the period. Metis Global Partners LLC’s holdings in ICL Group were worth $668,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ICL. Vanguard Group Inc. boosted its holdings in ICL Group by 1.6% in the first quarter. Vanguard Group Inc. now owns 25,286,822 shares of the basic materials company’s stock valued at $136,043,000 after purchasing an additional 392,805 shares during the period. Crossmark Global Holdings Inc. purchased a new stake in shares of ICL Group during the third quarter worth approximately $6,689,000. Y.D. More Investments Ltd raised its holdings in ICL Group by 2,927,153.2% in the second quarter. Y.D. More Investments Ltd now owns 14,636,266 shares of the basic materials company’s stock valued at $62,766,000 after acquiring an additional 14,635,766 shares in the last quarter. Assenagon Asset Management S.A. purchased a new position in ICL Group in the third quarter worth approximately $11,967,000. Finally, DekaBank Deutsche Girozentrale grew its holdings in ICL Group by 8.1% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 34,054 shares of the basic materials company’s stock worth $180,000 after acquiring an additional 2,542 shares in the last quarter. Institutional investors and hedge funds own 13.38% of the company’s stock.

ICL Group Stock Performance

Shares of ICL Group stock opened at $4.42 on Monday. The company has a quick ratio of 0.94, a current ratio of 1.56 and a debt-to-equity ratio of 0.30. ICL Group Ltd has a 52 week low of $3.79 and a 52 week high of $5.54. The firm’s 50 day moving average is $4.12 and its two-hundred day moving average is $4.34. The firm has a market capitalization of $5.81 billion, a P/E ratio of 14.26, a P/E/G ratio of 6.22 and a beta of 1.23.

ICL Group (NYSE:ICL) last released its quarterly earnings results on Monday, November 11th. The basic materials company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.08 by $0.03. ICL Group had a return on equity of 8.31% and a net margin of 5.83%. The company had revenue of $1.75 billion for the quarter, compared to analyst estimates of $1.73 billion. During the same quarter in the previous year, the company posted $0.11 earnings per share. Research analysts forecast that ICL Group Ltd will post 0.34 EPS for the current fiscal year.

ICL Group Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, December 4th will be paid a dividend of $0.0133 per share. This represents a $0.05 annualized dividend and a dividend yield of 1.20%. The ex-dividend date is Wednesday, December 4th. ICL Group’s dividend payout ratio (DPR) is presently 48.39%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ICL shares. StockNews.com upgraded shares of ICL Group from a “buy” rating to a “strong-buy” rating in a report on Tuesday, November 12th. Barclays decreased their price target on ICL Group from $4.50 to $4.00 and set an “underweight” rating for the company in a report on Friday, August 16th.

ICL Group Company Profile

ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.